Trivium Point Advisory LLC Makes New Investment in Tempus AI, Inc. $TEM

Key Points

• Trivium Point Advisory LLC acquired a new position in Tempus AI, purchasing 5,012 shares valued at approximately $242,000 in the 1st quarter.
• Multiple institutional investors raised their stakes in Tempus AI in the 4th quarter, with LPL Financial LLC increasing its ownership by 120.3% to hold 44,006 shares worth about $1.49 million.
• Tempus AI reported a revenue increase of 89.5% year-over-year, totaling $314.64 million, and had a negative net margin of 20.98% despite surpassing earnings expectations in its recent quarterly earnings.

Trivium Point Advisory LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 5,012 shares of the company's stock, valued at approximately $242,000.

Several other institutional investors have also modified their holdings of TEM. Cherry Tree Wealth Management LLC acquired a new position in Tempus AI in the 1st quarter worth about $31,000. University of Texas Texas AM Investment Management Co. bought a new position in shares of Tempus AI in the first quarter worth $33,000. Continuum Advisory LLC bought a new stake in Tempus AI during the first quarter valued at $39,000. Bartlett & CO. Wealth Management LLC increased its holdings in Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the period. Finally, Nemes Rush Group LLC bought a new stake in shares of Tempus AI in the 1st quarter worth approximately $39,000. Institutional investors own 24.22% of the company's stock.

Insider Activity at Tempus AI

In other Tempus AI news, Director Theodore Leonsis sold 205,847 shares of the business's stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the completion of the sale, the director owned 15,511 shares of the company's stock, valued at approximately $1,049,474.26. The trade was a 92.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO James William Rogers sold 23,121 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.27, for a total value of $1,462,865.67. Following the transaction, the chief financial officer directly owned 146,001 shares of the company's stock, valued at approximately $9,237,483.27. The trade was a 13.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 802,772 shares of company stock worth $54,080,775 in the last quarter. 27.60% of the stock is owned by company insiders.

Tempus AI Trading Up 3.1%

Shares of NASDAQ:TEM traded up $2.19 during mid-day trading on Friday, reaching $73.78. The stock had a trading volume of 14,646,490 shares, compared to its average volume of 10,537,207. The firm has a market cap of $12.82 billion, a PE ratio of -62.00 and a beta of 4.98. The firm has a 50 day simple moving average of $63.13 and a two-hundred day simple moving average of $58.64. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same period last year, the company posted ($6.86) earnings per share. The business's quarterly revenue was up 89.5% on a year-over-year basis. On average, research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TEM. Bank of America boosted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. Guggenheim increased their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Morgan Stanley raised their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Finally, Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $65.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.